the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs
September 21, 2022 – Here, a big bias in genetic research into its applicability on “personalized”, or “precision”, or “theragenomic” medicine is finally addressed and brought forward to all involved in these fields. The problem until now is (and was} that …
June 23, 2022 – Expansion of pharmacogenetics education agreed as part of lawsuit settlement. This has just been the headline objective of one of the latest blogs from the PharmGKB blogspot, an NIH-funded resource (database) that provides information about how …
Real world theragenomics and personalised medicine Read more »
July 26, 2019 – “Blockchains for secure digitized medicine”. This is the title of a very interesting and important article in the Journal of Personalised Medine (JPM) as of May 28, 2019. Blockchain as an emerging technology (particularly around the hype …
The phenotype broker: Blockchain and patient phenotype Read more »
March 31, 2018 – Are patients ready for direct-to-consumer genetic testing? This was the very important and central question that came up in the article by Matt Smith on Medscape, published March 29, 2018. Since thasso is all about theragenomic …
Direct-to-Consumer Genetic Testing: Are Patients Ready? Read more »
July 9, 2016 – This is a huge step into the future of theragenomic and personalized medicine and individualized drug safety. In support of the President’s Precision Medicine Initiative (PMI), the American Food & Drug Administration (FDA) just issued two …
Precision Medicine Initiative: draft guidances issued Read more »
February 8, 2015 – The American Food and Drug Administration (FDA) has granted accelerated approval to Palbociclib (Ibrance) to treat advanced (metastatic) breast cancer. The FDA granted Ibrance breakthrough therapy designation because the sponsor demonstrated through preliminary clinical evidence that the …
July 01, 2014 – As the knowledge of genetics and genomics rapidly expand, a personalized approach to health care is becoming increasingly important. India is fast becoming a promising contender in the global healthcare arena The majority of the global …
![The Apomediary [Patient Expert] and Personalized Medicine: A Commentary](https://thasso.com/wp-content/uploads/2014/06/Apomediary-II.png)
June 22, 2014 – The individuum (i.e., patient) is the phenotype expert on her/his individualized form of proper disease she/he is suffering from. It is not her/his treating physician, it is not a regulatory person concerned with the safety and …
The Apomediary [Patient Expert] and Personalized Medicine: A Commentary Read more »
Apple has unveiled HealthKit, a platform to centralise data from different types of devices, like fitness trackers, heart rate and blood pressure monitors. Launching iOS 8 for iPhones and iPads, which it describes as the biggest release since the launch …
April 23, 2014 – The U.S. Food and Drug Administration today approved Sylvant (siltuximab) to treat patients with multicentric Castleman’s disease (MCD), a rare disorder similar to lymphoma (cancer of the lymph nodes). MCD causes an abnormal overgrowth of immune …
FDA approves Siltuximab [Sylvant] for rare Castleman’s disease Read more »